Daqo New Energy Corp. (NYSE:DQ) (Daqo or the Company), a leading polysilicon manufacturer based in China, on 08 Aug 2014 announced that it plans to release its unaudited financial results for the second quarter of 2014 on Friday, August 15, 2014. The Company has scheduled a conference call to discuss the results at 8:00 AM Eastern Time on August 15, 2014. Daqo New Energy Corp. (NYSE:DQ) belongs to Technology sector. Its net profit margin is -36.40% and weekly performance is 0.97%. On last trading day company shares ended up $28.00. Daqo New Energy Corp. (NYSE:DQ) distance from 50-day simple moving average (SMA50) is 0.46%.

Goldcorp Inc. (NYSE:GG) is preferred not only by Oppenheimer. Many Wall Street firms believe the miner has the ability to pursue an acquisition to refill its longer-term project pipeline. The company operates as a gold producer involved in the exploration, development and acquisition of metal properties in Canada, the United States, Mexico and Central and South America. Goldcorp Inc. (NYSE:GG) shares increased 2.05% in last trading session and ended the day at $28.83. GG Gross Margin is 27.10% and its return on assets is -8.10%. Goldcorp Inc. (NYSE:GG) quarterly performance is 16.34%.

Assurant Inc. (NYSE:AIZ) promoted Eric Greenman to CIO this week and Hartford Financial Services Group Inc. in May appointed Brion Johnson to oversee its investments. On 12 August, Assurant Inc. (NYSE:AIZ) shares increased 0.30% and was closed at $64.03. AIZ EPS growth in last 5 year was 10.90%. Assurant Inc. (NYSE:AIZ) year to date (YTD) performance is -2.75%.

Hyperion Therapeutics, Inc. (NASDAQ:HPTX) today announced the appointment of Theodore “Ted” Schroeder to its board of directors effective August 11, 2014. Mr. Schroeder has over two decades of experience in the life sciences industry. Most recently, he was the founder of Cadence Pharmaceuticals, Inc., serving as its president and chief executive officer from inception until its acquisition by Mallinckrodt Pharmaceuticals earlier this year. Hyperion Therapeutics, Inc. (NASDAQ:HPTX) ended the last trading day at $23.51. Company weekly volatility is calculated as 4.08%and price to cash ratio as 3.95. Hyperion Therapeutics, Inc. (NASDAQ:HPTX) showed a weekly performance of 4.07%.

Everyday Health (NASDAQ:EVDY)‘s stock had its “buy” rating reaffirmed by equities researchers at Citigroup Inc. in a research report issued on Tuesday. They currently have a $20.00 price objective on the stock, up from their previous price objective of $18.00. Citigroup Inc.’s price objective would suggest a potential upside of 18.20% from the company’s current price. Everyday Health, Inc. (NYSE:EVDY) shares moved down -2.07% in last trading session and ended the day on $16.57. EVDY Gross Margin is 72.40% and its return on assets is -9.10%. Everyday Health, Inc. (NYSE:EVDY) quarterly performance is 19.04%.